Mead, Gillian E,
Sposato, Luciano A,
Sampaio Silva, Gisele,
Yperzeele, Laetitia,
Wu, Simiao,
Kutlubaev, Mansur,
Cheyne, Joshua,
Wahab, Kolawole,
Urrutia, Victor C,
Sharma, Vijay K,
Sylaja, PN,
Hill, Kelvin,
Steiner, Thorsten,
David S, Liebeskind,
Rabinstein, lejandro A (2023) for reperfusion therapies for acute ischemic
stroke. For
secondary prevention, strong recommendations included
Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) Background: Post-
stroke fatigue (PSF) affects around 50% of
stroke survivors. Previous systematic
Depression and anxiety each affect around 1 in 3 people during the first year after a
strokeGuan, Xiaoxiang,
Zhang, Yiwei,
Gareev, Ilgiz,
Beylerli, Ozal,
Li, Xinyuan,
Lu, Guitian,
Lv, Lin,
Hai, Xin (2023) MiR-499a
prevents astrocytes mediated inflammation in ischemic
stroke by targeting PTEN
Guan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) Introduction: Ischemic
stroke (IS) is a common and severe neurological disorder and is associated
Wang, CL,
Zheng, BJ,
Gareev, I,
Beylerli, O,
Gu, Y,
Xu, SC,
Ji, ZY,
Wu, P,
Shi, HZ (2021) Acute ischemic
stroke (AIS) continues to be one of the most important medical and social problems
LEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) , type of
stroke, time since
stroke, our primary and
secondary outcomes, and sources of bias. Two review
Wu, S.,
Kutlubaev, M.A.,
Chun, Ho-Yan Y,
Cowey, E.,
Pollock, A.,
Macleod, M.R.,
Dennis, M.,
Keane, E.,
Sharpe, M.,
Mead, G.E (2015) the efficacy in
preventing PSF.
Four trials (248 participants) did not primarily investigate the efficacy
Intracerebral hemorrhage (ICH) is one of the most devastating and life-threatening forms of
stroke